ANIX
Anixa Biosciences Inc
NASDAQ: ANIX · HEALTHCARE · BIOTECHNOLOGY
$3.00
+4.17% today
Updated 2026-04-30
Market cap
$102.26M
P/E ratio
—
P/S ratio
377.78x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$2 – $5
Volume
0.1M
Anixa Biosciences Inc (ANIX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-68.10%
ROA
-40.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $508651.00 | $-7.60M | 69.24% | -1,499.58% | -1,494.33% |
| 2007 | $486852.00 | $-5.46M | 67.06% | -1,128.14% | -1,121.12% |
| 2008 | $2.06M | $-5.82M | 95.37% | -290.31% | -282.17% |
| 2009 | $1.06M | $-16.49M | 93.78% | -693.35% | -1,561.76% |
| 2010 | $730675.00 | $-5.18M | 88.74% | -718.27% | -708.27% |
| 2011 | $1.00M | $-7.38M | 96.60% | -501.23% | -735.46% |
| 2012 | $940010.00 | $-4.25M | 100.00% | -439.84% | -452.42% |
| 2013 | $388850.00 | $-10.08M | 18.57% | -2,036.17% | -2,592.28% |
| 2014 | $3.67M | $-9.61M | 45.79% | -137.54% | -261.94% |
| 2015 | $9.26M | $-1.38M | 60.58% | -10.21% | -14.90% |
| 2016 | $300000.00 | $-5.02M | 27.53% | -1,503.00% | -1,672.14% |
| 2017 | $362500.00 | $-5.01M | 71.16% | -1,676.02% | -1,381.79% |
| 2018 | $1.11M | $-14.00M | 1.69% | -1,232.01% | -1,258.07% |
| 2019 | $250000.00 | $-11.65M | 33.50% | -4,756.00% | -4,658.82% |
| 2020 | $0.00 | $-10.13M | — | — | — |
| 2021 | $512000.00 | $-12.95M | 24.80% | -2,565.56% | -2,528.64% |
| 2022 | $2.47B | $-13.60M | 100.00% | -0.56% | -0.55% |
| 2023 | $210000.00 | $-9.81M | 23.33% | -5,243.33% | -4,671.90% |
| 2024 | $0.00 | $-12.55M | — | — | — |
| 2025 | $0.00 | $-10.93M | — | — | — |